| Field | Row 1 |
|---|---|
| adsh | 0000950170-25-061442 |
| cik | 1680581 |
| name | FULCRUM THERAPEUTICS, INC. |
| sic | 2834 |
| countryba | US |
| stprba | MA |
| cityba | CAMBRIDGE |
| zipba | 02139 |
| bas1 | 26 LANDSDOWNE STREET |
| bas2 | |
| baph | 617-651-8851 |
| countryma | US |
| stprma | MA |
| cityma | CAMBRIDGE |
| zipma | 02139 |
| mas1 | 26 LANDSDOWNE STREET |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 474839948 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250501 |
| accepted | 2025-05-01 07:10:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | fulc-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-061442 | 20240331 | Accretion Amortization Of Discounts And Premiums Investments | 1161000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -3921000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -3340000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Interest Income Expense Nonoperating Net | 2964000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Operating Expenses | 29834000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Operating Expenses | 2098000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; Product Or Service= Pociredir; | ||
| 0000950170-25-061442 | 20240331 | Operating Expenses | 3665000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; Product Or Service= Pre- Development Candidate Expenses; | ||
| 0000950170-25-061442 | 20250331 | Operating Expenses | 4264000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; Product Or Service= Pociredir; | ||
| 0000950170-25-061442 | 20250331 | Operating Expenses | 4053000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; Product Or Service= Pre- Development Candidate Expenses; | ||
| 0000950170-25-061442 | 20250331 | Operating Income Loss | -20403000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Other Liabilities Noncurrent | 197000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Preferred Stock Shares Authorized | 5000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Prepaid Expense And Other Assets Current | 4974000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Restricted Cash Noncurrent | 1201000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Share Based Compensation | 1329000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Research And Development Expense; | ||
| 0000950170-25-061442 | 20231231 | Shares Outstanding | 61915367.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-061442 | 20240331 | Stockholders Equity | -536543000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-061442 | 20241231 | Stockholders Equity | 243034000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Stockholders Equity | 130000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-061442 | 20241231 | Stockholders Equity | 762248000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-061442 | 20241231 | Stock Issued During Period Shares Restricted Stock Award Gross | 43072.0000 | shares | 4 | us-gaap/2024 | Award Type= Restricted Stock Units R S U; | ||
| 0000950170-25-061442 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 62479000.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Accounts Payable Current | 1507000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Accrued Liabilities And Other Current Liabilities | 7694000.0000 | USD | 0 | 0000950170-25-061442 | |||
| 0000950170-25-061442 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 130000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Assets Current | 249923000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Cash And Cash Equivalents At Carrying Value | 42178000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 41150000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 43379000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-061442 | 20240331 | General And Administrative Expense | 10061000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-061442 | 20240331 | Increase Decrease In Accounts Payable | 1100000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Increase Decrease In Accounts Receivable | -1117000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Marketable Securities | 184425000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Net Cash Provided By Used In Financing Activities | 1651000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Operating Expenses | 20403000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-061442 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -298000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Payments To Acquire Property Plant And Equipment | 28000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Research And Development Expense | 19773000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Shares Outstanding | 53968303.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-061442 | 20231231 | Stockholders Equity | 744940000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-061442 | 20250331 | Stockholders Equity | 54000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-061442 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 62479000.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Additional Paid In Capital Common Stock | 765415000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 70000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Cash And Cash Equivalents At Carrying Value | 58212000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Common Stock Shares Issued | 53979306.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Depreciation | 353000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | General And Administrative Expense | 10061000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Net Income Loss | -26870000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-061442 | 20240331 | Operating Expenses | 29834000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-061442 | 20240331 | Operating Income Loss | -29834000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-061442 | 20241231 | Operating Lease Right Of Use Asset | 5684000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -298000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-061442 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Proceeds From Issuance Of Common Stock | 1651000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Restricted Cash Noncurrent | 1201000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Restricted Cash Noncurrent | 1201000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Share Based Compensation | 3916000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Share Based Compensation | 2183000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= General And Administrative Expense; | ||
| 0000950170-25-061442 | 20231231 | Stockholders Equity | 62000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-061442 | 20240331 | Stockholders Equity | 750507000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-061442 | 20240331 | Stockholders Equity | 62000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-061442 | 20241231 | Stockholders Equity | 54000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-061442 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Gross | 88048.0000 | shares | 1 | us-gaap/2024 | Award Type= Restricted Stock Units R S U; | ||
| 0000950170-25-061442 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3167000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3167000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-061442 | 20241231 | Assets | 260718000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Assets Current | 232556000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Common Stock Shares Authorized | 200000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Common Stock Shares Outstanding | 53968303.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Common Stock Shares Outstanding | 53979306.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Comprehensive Income Net Of Tax | -17715000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Depreciation | 479000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Earnings Per Share Basic | -0.4300 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Earnings Per Share Basic | -0.2800 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Increase Decrease In Other Operating Assets | -23000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -1832000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Interest Income Expense Nonoperating Net | 2964000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-061442 | 20250331 | Interest Income Expense Nonoperating Net | 2748000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-061442 | 20250331 | Liabilities And Stockholders Equity | 242649000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Marketable Securities | 182809000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Net Income Loss | -26870000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Operating Income Loss | -20403000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-061442 | 20250331 | Operating Lease Liability Noncurrent | 5866000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Operating Lease Right Of Use Asset | 5335000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Prepaid Expense And Other Assets Current | 6806000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Retained Earnings Accumulated Deficit | -519398000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Stockholders Equity | 228486000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Stockholders Equity | 70000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-061442 | 20250331 | Stockholders Equity | -537053000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-061442 | 20240331 | Stock Issued During Period Value Employee Benefit Plan | 1651000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-061442 | 20241231 | Accounts Payable Current | 1164000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 59413000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Common Stock Shares Authorized | 200000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Common Stock Shares Issued | 53968303.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Earnings Per Share Diluted | -0.4300 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Earnings Per Share Diluted | -0.2800 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Net Cash Provided By Used In Financing Activities | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Operating Lease Liability Current | 2186000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Operating Lease Liability Noncurrent | 6443000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Other Comprehensive Income Loss Net Of Tax | -298000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Other Comprehensive Income Loss Net Of Tax | -60000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Other Liabilities Noncurrent | 197000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Payments To Acquire Property Plant And Equipment | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Preferred Stock Shares Authorized | 5000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Proceeds From Maturity Of Marketable Securities | 93972000.0000 | USD | 1 | 0000950170-25-061442 | |||
| 0000950170-25-061442 | 20250331 | Proceeds From Maturity Of Marketable Securities | 59620000.0000 | USD | 1 | 0000950170-25-061442 | |||
| 0000950170-25-061442 | 20240331 | Profit Loss | -26870000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Property Plant And Equipment Net | 3900000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Retained Earnings Accumulated Deficit | -537053000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Shares Outstanding | 62141011.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-061442 | 20250331 | Shares Outstanding | 53979306.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-061442 | 20240331 | Stockholders Equity | -434000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-061442 | 20240331 | Stock Issued During Period Value Employee Benefit Plan | 1651000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Unbilled Receivables Current | 2096000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Unbilled Receivables Current | 979000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 61984000.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Accretion Amortization Of Discounts And Premiums Investments | 899000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Accrued Liabilities And Other Current Liabilities | 4354000.0000 | USD | 0 | 0000950170-25-061442 | |||
| 0000950170-25-061442 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3916000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3916000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-061442 | 20250331 | Common Stock Value | 54000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Comprehensive Income Net Of Tax | -27168000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | General And Administrative Expense | 6999000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-061442 | 20250331 | Liabilities | 14163000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Operating Expenses | 1024000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; Product Or Service= Losmapimod; | ||
| 0000950170-25-061442 | 20241231 | Other Assets Noncurrent | 10000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -60000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Payments To Acquire Marketable Securities | 60397000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Stockholders Equity | 765415000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0000950170-25-061442 | 20240331 | Stock Issued During Period Shares Employee Benefit Plan | 214094.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-061442 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 61984000.0000 | shares | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 8500000.0000 | shares | 1 | us-gaap/2024 | Class Of Stock= Common Stock; | ||
| 0000950170-25-061442 | 20241231 | Additional Paid In Capital Common Stock | 762248000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Cash And Cash Equivalents At Carrying Value | 39949000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 26655000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -16034000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Cash Paid For Operating Lease Liabilities | 843000.0000 | USD | 1 | 0000950170-25-061442 | |||
| 0000950170-25-061442 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0000950170-25-061442 | 20240831 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Ra Capital; | ||
| 0000950170-25-061442 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | General And Administrative Expense | 6999000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Increase Decrease In Accounts Receivable | -537000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Increase Decrease In Operating Lease Assets And Liabilities | 175000.0000 | USD | 1 | 0000950170-25-061442 | |||
| 0000950170-25-061442 | 20250331 | Increase Decrease In Other Operating Assets | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Interest Income Expense Nonoperating Net | 2748000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Liabilities | 17684000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Liabilities And Stockholders Equity | 260718000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Liabilities Current | 11044000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Net Cash Provided By Used In Operating Activities | -15257000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Net Income Loss | -17655000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-061442 | 20240331 | Operating Income Loss | -29834000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Operating Lease Liability Current | 2239000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Payments To Acquire Marketable Securities | 55816000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Profit Loss | -17655000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Research And Development Expense | 13404000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Share Based Compensation | 2587000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= General And Administrative Expense; | ||
| 0000950170-25-061442 | 20231231 | Stockholders Equity | 235193000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20231231 | Stockholders Equity | -136000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-061442 | 20241231 | Stockholders Equity | -519398000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-061442 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Gross | 11550.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-061442 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Gross | 11003.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0000950170-25-061442 | 20250331 | Assets | 242649000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 14495000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Cash Paid For Operating Lease Liabilities | 652000.0000 | USD | 1 | 0000950170-25-061442 | |||
| 0000950170-25-061442 | 20241231 | Common Stock Value | 54000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Increase Decrease In Accounts Payable | 343000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Increase Decrease In Operating Lease Assets And Liabilities | 190000.0000 | USD | 1 | 0000950170-25-061442 | |||
| 0000950170-25-061442 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -803000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Liabilities Current | 8100000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Net Cash Provided By Used In Investing Activities | 38128000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Net Cash Provided By Used In Investing Activities | -777000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Net Cash Provided By Used In Operating Activities | -25284000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20240331 | Net Income Loss | -26870000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-061442 | 20250331 | Net Income Loss | -17655000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Net Income Loss | -17655000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0000950170-25-061442 | 20240331 | Operating Expenses | 8294000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; Product Or Service= Losmapimod; | ||
| 0000950170-25-061442 | 20250331 | Operating Expenses | 20403000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Other Assets Noncurrent | 10000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -60000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0000950170-25-061442 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Proceeds From Issuance Of Common Stock | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Property Plant And Equipment Net | 3547000.0000 | USD | 0 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Share Based Compensation | 3167000.0000 | USD | 1 | us-gaap/2024 | |||
| 0000950170-25-061442 | 20250331 | Share Based Compensation | 984000.0000 | USD | 1 | us-gaap/2024 | Income Statement Location= Research And Development Expense; | ||
| 0000950170-25-061442 | 20231231 | Stockholders Equity | -509673000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0000950170-25-061442 | 20240331 | Stockholders Equity | 213592000.0000 | USD | 0 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Restricted Stock Award, Gross | Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. | |
| Unbilled Receivables Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Unbilled Receivables, Current | Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Interest Income Expense Nonoperating Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Income (Expense), Nonoperating | Amount of interest income (expense) classified as nonoperating. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Cash Paid For Operating Lease Liabilities | 0000950170-25-061442 | 1 | 0 | monetary | D | C | Cash paid for operating lease liabilities | Cash paid for operating lease liabilities |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Other Operating Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Operating Assets | Amount of increase (decrease) in operating assets classified as other. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Stock Issued During Period Shares Employee Benefit Plan | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Employee Benefit Plan | Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan. | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax | Amount after tax and reclassification adjustments of other comprehensive income (loss). |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Accrued Liabilities And Other Current Liabilities | 0000950170-25-061442 | 1 | 0 | monetary | I | C | Accrued Liabilities And Other Current Liabilities | Accrued liabilities and other current liabilities. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | Amount of increase (decrease) in accrued expenses, and obligations classified as other. |
| Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | I | D | Marketable Securities | Amount of investment in marketable security. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Other Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Restricted Cash Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash, Noncurrent | Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Increase Decrease In Operating Lease Assets And Liabilities | 0000950170-25-061442 | 1 | 0 | monetary | D | C | Increase Decrease In Operating Lease Assets And Liabilities | Increase Decrease In Operating Lease Assets And Liabilities |
| Proceeds From Maturity Of Marketable Securities | 0000950170-25-061442 | 1 | 0 | monetary | D | D | Proceeds From Maturity Of Marketable Securities | Proceeds from maturity of marketable securities. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Payments To Acquire Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Marketable Securities | Amount of cash outflow for purchase of marketable security. |
| Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Accretion (Amortization) of Discounts and Premiums, Investments | The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Stock Issued During Period Value Employee Benefit Plan | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Employee Benefit Plan | Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0000950170-25-061442 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-061442 | 2 | 4 | BS | 0 | H | Marketable Securities | us-gaap/2024 | Marketable securities | 0 |
| 0000950170-25-061442 | 2 | 5 | BS | 0 | H | Unbilled Receivables Current | us-gaap/2024 | Unbilled accounts receivable | 0 |
| 0000950170-25-061442 | 2 | 6 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0000950170-25-061442 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0000950170-25-061442 | 2 | 8 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0000950170-25-061442 | 2 | 9 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use assets | 0 |
| 0000950170-25-061442 | 2 | 10 | BS | 0 | H | Restricted Cash Noncurrent | us-gaap/2024 | Restricted cash | 0 |
| 0000950170-25-061442 | 2 | 11 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other assets | 0 |
| 0000950170-25-061442 | 2 | 12 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0000950170-25-061442 | 2 | 15 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-061442 | 2 | 16 | BS | 0 | H | Accrued Liabilities And Other Current Liabilities | 0000950170-25-061442 | Accrued expenses and other current liabilities | 0 |
| 0000950170-25-061442 | 2 | 17 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating Lease Liability, current | 0 |
| 0000950170-25-061442 | 2 | 18 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0000950170-25-061442 | 2 | 19 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liability, excluding current portion | 0 |
| 0000950170-25-061442 | 2 | 20 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2024 | Other liabilities, excluding current portion | 0 |
| 0000950170-25-061442 | 2 | 21 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0000950170-25-061442 | 2 | 22 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 12) | 0 |
| 0000950170-25-061442 | 2 | 24 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued or outstanding | 0 |
| 0000950170-25-061442 | 2 | 25 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.001 par value; 200,000,000 shares authorized; 53,979,306 and 53,968,303 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 0 |
| 0000950170-25-061442 | 2 | 26 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
| 0000950170-25-061442 | 2 | 27 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive gain | 0 |
| 0000950170-25-061442 | 2 | 28 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0000950170-25-061442 | 2 | 29 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders equity | 0 |
| 0000950170-25-061442 | 2 | 30 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders equity | 0 |
| 0000950170-25-061442 | 3 | 1 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value | 0 |
| 0000950170-25-061442 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
| 0000950170-25-061442 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
| 0000950170-25-061442 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
| 0000950170-25-061442 | 3 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0000950170-25-061442 | 3 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0000950170-25-061442 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0000950170-25-061442 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0000950170-25-061442 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0000950170-25-061442 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0000950170-25-061442 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0000950170-25-061442 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0000950170-25-061442 | 4 | 6 | IS | 0 | H | Interest Income Expense Nonoperating Net | us-gaap/2024 | Other income, net | 0 |
| 0000950170-25-061442 | 4 | 7 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0000950170-25-061442 | 4 | 8 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net (loss) income per share, basic | 0 |
| 0000950170-25-061442 | 4 | 9 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share, basic and diluted | 0 |
| 0000950170-25-061442 | 4 | 10 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted-average common shares outstanding, basic | 0 |
| 0000950170-25-061442 | 4 | 11 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted-average common shares outstanding, diluted | 0 |
| 0000950170-25-061442 | 4 | 13 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net Income (Loss) | 0 |
| 0000950170-25-061442 | 4 | 15 | IS | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | Unrealized loss on marketable securities | 0 |
| 0000950170-25-061442 | 4 | 16 | IS | 0 | H | Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Total other comprehensive loss | 0 |
| 0000950170-25-061442 | 4 | 17 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive loss | 0 |
| 0000950170-25-061442 | 5 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning balance | 0 |
| 0000950170-25-061442 | 5 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning balance, Shares | 0 |
| 0000950170-25-061442 | 5 | 11 | EQ | 0 | H | Stock Issued During Period Value Employee Benefit Plan | us-gaap/2024 | Issuance of common stock under employee benefit plans | 0 |
| 0000950170-25-061442 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Shares Employee Benefit Plan | us-gaap/2024 | Issuance of common stock under employee benefit plans, Shares | 0 |
| 0000950170-25-061442 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Gross | us-gaap/2024 | Vesting of restricted stock awards, Shares | 0 |
| 0000950170-25-061442 | 5 | 15 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation expense | 0 |
| 0000950170-25-061442 | 5 | 16 | EQ | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2024 | Unrealized loss on marketable securities | 0 |
| 0000950170-25-061442 | 5 | 17 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net Income (Loss) | 0 |
| 0000950170-25-061442 | 5 | 18 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending balance | 0 |
| 0000950170-25-061442 | 5 | 19 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending balance, Shares | 0 |
| 0000950170-25-061442 | 6 | 6 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net income (loss) | 0 |
| 0000950170-25-061442 | 6 | 8 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation expense | 0 |
| 0000950170-25-061442 | 6 | 9 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation expense | 0 |
| 0000950170-25-061442 | 6 | 10 | CF | 0 | H | Accretion Amortization Of Discounts And Premiums Investments | us-gaap/2024 | Net accretion of discounts on marketable securities | 1 |
| 0000950170-25-061442 | 6 | 12 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Unbilled accounts receivable | 1 |
| 0000950170-25-061442 | 6 | 13 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0000950170-25-061442 | 6 | 14 | CF | 0 | H | Increase Decrease In Operating Lease Assets And Liabilities | 0000950170-25-061442 | Operating lease assets and liabilities | 1 |
| 0000950170-25-061442 | 6 | 15 | CF | 0 | H | Increase Decrease In Other Operating Assets | us-gaap/2024 | Other assets | 1 |
| 0000950170-25-061442 | 6 | 16 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0000950170-25-061442 | 6 | 17 | CF | 0 | H | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2024 | Accrued expenses and other liabilities | 0 |
| 0000950170-25-061442 | 6 | 18 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0000950170-25-061442 | 6 | 20 | CF | 0 | H | Payments To Acquire Marketable Securities | us-gaap/2024 | Purchases of marketable securities | 1 |
| 0000950170-25-061442 | 6 | 21 | CF | 0 | H | Proceeds From Maturity Of Marketable Securities | 0000950170-25-061442 | Maturities of marketable securities | 0 |
| 0000950170-25-061442 | 6 | 22 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchases of property and equipment | 1 |
| 0000950170-25-061442 | 6 | 23 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash (used in) provided by investing activities | 0 |
| 0000950170-25-061442 | 6 | 25 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Proceeds from issuance of common stock under benefit plans, net | 0 |
| 0000950170-25-061442 | 6 | 26 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0000950170-25-061442 | 6 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net (decrease) increase in cash, cash equivalents and restricted cash | 0 |
| 0000950170-25-061442 | 6 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash, cash equivalents, and restricted cash, beginning of period | 0 |
| 0000950170-25-061442 | 6 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash, cash equivalents, and restricted cash, end of period | 0 |
| 0000950170-25-061442 | 6 | 31 | CF | 0 | H | Cash Paid For Operating Lease Liabilities | 0000950170-25-061442 | Cash paid for operating lease liabilities | 0 |
| 0000950170-25-061442 | 6 | 32 | CF | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0000950170-25-061442 | 6 | 33 | CF | 0 | H | Restricted Cash Noncurrent | us-gaap/2024 | Restricted cash | 0 |
| 0000950170-25-061442 | 6 | 34 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Total cash, cash equivalents, and restricted cash | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |